Kyivmedpreparat’s and Halychpharm’s new pharmacy storage facilities located in Chaiky village (Kyivo-Sviatoshynskyi Raion) are now opened for our distributors. Arterium has procured pharmaceutical drug manufacturing and wholesale sale licenses for both warehouses in May 2014.

The Healthcare Ministry of Ukraine has approved the List of Emergency Medical Assistance Drugs used by emergency medical assistance centers, departments, stations and crews.

Arterium Corporation launches Dimaryl, its new drug, on Ukrainian market. This is an antidiabetic drug to be used as a part of combination therapy for non-insulin-dependent type II diabetes. It contains glimepiride as an active pharmaceutical ingredient.

Arterium specialists presented the company to students during their visits in September – November to Ukrainian higher educational institutions. The Arterium team visited the National Technical University “Kyiv Polytechnic Institute”, National University of Food Technologies, National Taras Shevchenko University, Odesa Polytechnic University, Odesa Mechnikov University, Kyiv National University of Technology and Design, Bogomolets National Medical University, and Zhytomyr State University.

Arterium has become a title sponsor for the opening ceremony at the Third National Congress with International Participation “Stroke and Cerebrovascular Disorders” held in early November in Kyiv. The Congress was held by the Ukrainian Anti-Stroke Association in cooperation with the Ministry of Health of Ukraine, National Academy of Medical Sciences of Ukraine, and P.L. Shupyk National Academy of Postgraduate Education.

The Eighth Congress of the Ukrainian Endocrinologists’ Association was held in 20^th – 22^nd of October in Kyiv by the Ministry of Health of Ukraine, the National Academy of Medical Sciences of Ukraine, Association of Endocrinologists of Ukraine and Komisarenko Institute of Endocrinology and Metabolism of the Academy of Medical Sciences of Ukraine. Arterium Corporation was invited as a partner.